Orkla ASA: Status share buy-back programme

Summary by AI ^BETAClose X

Orkla ASA has provided an update on its share buy-back program, which commenced on November 14, 2025, and is scheduled to conclude on December 31, 2026. Between December 3rd and December 9th, 2025, the company repurchased a total of 1,620,000 shares, with daily transaction values ranging from approximately NOK 34.36 million to NOK 35.80 million. Cumulatively, the buy-back program has now acquired 4,470,000 shares for a total of NOK 479,830,772, at an average price of NOK 107.3447 per share. Following these transactions, Orkla ASA holds 8,573,391 own shares, representing 0.86% of its share capital.

Disclaimer*

Transactions made under the buy-back programme for Orkla ASA

Date on which the buy-back programme was announced: 14 November 2025

The duration of the buy-back programme: 31 December 2026

Overview of transactions:

Date	Aggregated daily volume (number of shares)	Weighted average share price per day (NOK)	Total daily transaction value (NOK)
03/12/2025	320,000	107.3602	34,355,264
04/12/2025	320,000	107.5077	34,402,464
05/12/2025	325,000	107.7181	35,008,383
08/12/2025	325,000	107.3510	34,889,075
09/12/2025	330,000	108.4744	35,796,552
Previously disclosed buybacks under the programme (accumulated)	2,850,000	107.1505	305,379,035
Accumulated under the buyback programme	4,470,000	107.3447	479,830,772

The issuer's holding of own shares: Following the completion of the above transactions, Orkla ASA owns a total of 8,573,391 of own shares, corresponding to 0.86% of Orkla ASA's share capital.

Appendix: An overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned period is attached to this stock exchange announcement and available at www.newsweb.no.

Ref.:

Investor Relations Manager
Ole Andreas Steensland Dahl
Mail: oasd@orkla.no
Mob.: +47 907 07 937

This is information that Orkla ASA is obliged to make public pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.